サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545579

薬物検査の世界市場

Drug Screening
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 202 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.41円
薬物検査の世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 202 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

薬物検査の世界市場は2030年までに282億米ドルに達する見込み

2023年に97億米ドルと推定される薬物検査の世界市場は、2023年から2030年にかけて14.4%のCAGRで成長し、2030年には282億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである薬物検査製品は、CAGR 12.1％を記録し、分析期間終了時には149億米ドルに達すると予測されます。薬物検査サービス分野は、今後8年間のCAGR成長率が17.4％と予測されています。

米国市場は30億米ドル、中国はCAGR13.8％で成長予測

米国の薬物検査市場は、2023年には30億米ドルに達すると推定されます。世界第2位の経済大国である中国は、2023年から2030年までの分析期間においてCAGR 13.8%で推移し、2030年には49億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、それぞれ2023年から2030年にかけて12.5%と12.3%の成長が予測されています。欧州では、ドイツがCAGR約10.6%で成長すると予測されています。

2024年向け新レポートの特徴

  • インフルエンサーのエンゲージメント統計へのフルアクセス
  • デジタルアーカイブと"MarketGlass"リサーチプラットフォームへの無料アクセス。当社独自のMarketGlassプラットフォームは、世界中の専門家の創造性と市場知識を統合的かつコラボレーティブに提供します。当社の最新鋭ツールは、参加者のプライバシーとアイデンティティを保護しながら、世界クラスの市場展望をもたらします。本レポートに掲載されている数字、統計、市場に関する説明は、この分野の専門家やインフルエンサーによって共有された、完全に精査された洞察に基づいています。
  • リアルタイムのデータシミュレーター・ツールや特注のレポート作成機能を備えたインタラクティブなアンケートに参加できます。
  • 企業間のスマートな意見交換のためのピアコラボレーティブ・インタラクティブプラットフォームへのフルクライアントアクセス
  • 1年間の無料レポート更新
  • 主要企業の世界市場シェアを含む競合カバレッジ
  • 複数の地域にまたがる企業の市場プレゼンス分析（好調/活発/ニッチ/マイナー）
  • 専門家/インフルエンサーのインタビュー、ポッドキャスト、プレス発表、イベント基調講演のYouTubeビデオへのアクセス

2024年の世界経済に期待すること

金融引き締めとそれに伴う金利上昇による地政学的な影響と経済の不安定性が、2024年の世界経済を波乱に満ちたものにすると思われます。中東での敵対行為や、ますます頻発する気候災害など、いくつかの要因が回復への道筋に圧力をかけ続けると思われます。リスクの一方で、ディスインフレの兆候が強まり、頑迷なインフレに対する不安が緩和され、サプライチェーンが正常化し、エネルギーコストの変動にもかかわらず物価が緩やかになるなど、いくつかのプラス材料も具体化しつつあります。インドや米国をはじめとするG21諸国の選挙は、資本の流れや投資戦略に影響を与える可能性があります。インドが世界な投資先として注目される一方で、米国を拠点とするハイテク企業は、才能と資本のダイナミックなエコシステムに後押しされ、引き続き優位を保つと思われます。シリコンバレーをはじめとするハイテク機会は、国内経済が減速しているとはいえ底堅く、規制環境も整備されていることから、高成長の可能性を求める投資家にとって引き続き魅力的です。欧州は金融引き締め政策と景気後退リスクとの戦いが続くが、英国は見通しが最も厳しく、2024年の景気後退リスクが最も高いです。中国は、政府支出と個人消費の改善に支えられた成長が期待されるもの、引き続きワイルドカードとなります。不安定な環境は、投資家にも企業にもチャンスと課題の両方をもたらすと思われます。成長への触媒としてボラティリティを受け入れるとともに、敏捷性と戦略的な先見性をもって投資判断に臨むことが、生き残りのために重要であることに変わりはないです。

調査対象企業の例（全53件）

  • Alere, Inc.
  • Alfa Scientific Designs, Inc.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings（LabCorp）
  • Lifeloc Technologies, Inc.
  • Mpd, Inc.
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11648

Global Drug Screening Market to Reach $28.2 Billion by 2030

The global market for Drug Screening estimated at US$9.7 Billion in the year 2023, is expected to reach US$28.2 Billion by 2030, growing at a CAGR of 14.4% over the period 2023-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record 12.1% CAGR and reach US$14.9 Billion by the end of the analysis period. Growth in the Drug Screening Services segment is estimated at 17.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 13.8% CAGR

The Drug Screening market in the U.S. is estimated at US$3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 13.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 12.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 53 Featured) -

  • Alere, Inc.
  • Alfa Scientific Designs, Inc.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Lifeloc Technologies, Inc.
  • Mpd, Inc.
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Drug Screening - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Substance Abuse Drives Demand for Comprehensive Drug Screening Solutions
    • Advances in Immunoassay and Mass Spectrometry Propel Growth in Drug Screening Market
    • Increasing Focus on Workplace Safety and Compliance Strengthens Business Case for Drug Screening
    • Rising Adoption of Drug Screening in Healthcare and Rehabilitation Centers Expands Market Opportunities
    • Growing Use of Drug Screening in Law Enforcement and Forensic Toxicology Drives Market Demand
    • Increasing Investments in Public Health and Safety Initiatives Propel Growth in Drug Screening Market
    • Technological Innovations in Lab-on-a-Chip and Microfluidics Propel Adoption in Drug Screening Solutions
    • Growing Applications of Drug Screening in Sports and Athletics Drive Market Expansion
    • Rising Demand for Home and At-Home Testing Kits Expands Addressable Market for Consumer-Driven Drug Screening
    • Increasing Use of Drug Screening in Criminal Justice and Corrections Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Breath by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Oral Fluid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Drug Screening Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • CHINA
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030

IV. COMPETITION